Search research articles
Contact Us
Filters
Showing results (281-290 of 489) with videos related to
Page
of 49
Sort By:
Neurobiology of Aging
|
May 9, 2017
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease
Suzanne E Schindler, Mateusz S Jasielec, Hua Weng, et al.
Annals of Neurology
|
July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
Molecular Neurodegeneration
|
April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects
Saori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology
|
May 1, 2016
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid
Yo-El S Ju, Mary Beth Finn, Courtney L Sutphen, et al.
Neurology
|
January 14, 2011
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease
C M Roe, A M Fagan, M M Williams, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
JAMA Neurology
|
August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity
Liang Wang, Matthew R Brier, Abraham Z Snyder, et al.
Brain Sciences
|
March 28, 2024
White Matter Integrity and Motor Function Disruption Due to Traumatic Brain Injury in Piglets: Impacts on Motor-Related Brain Fibers
Madison M Fagan, Kelly M Scheulin, Sydney E Sneed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 26, 2022
Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults
Chengjie Xiong, Jingqin Luo, Suzanne E Schindler, et al.
The Lancet. Neurology
|
September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 489) with videos related to
Sort By:
Page
of 49
Neurobiology of Aging
|
May 9, 2017
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease
Suzanne E Schindler, Mateusz S Jasielec, Hua Weng, et al.
Annals of Neurology
|
July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
Molecular Neurodegeneration
|
April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects
Saori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology
|
May 1, 2016
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid
Yo-El S Ju, Mary Beth Finn, Courtney L Sutphen, et al.
Neurology
|
January 14, 2011
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease
C M Roe, A M Fagan, M M Williams, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
JAMA Neurology
|
August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity
Liang Wang, Matthew R Brier, Abraham Z Snyder, et al.
Brain Sciences
|
March 28, 2024
White Matter Integrity and Motor Function Disruption Due to Traumatic Brain Injury in Piglets: Impacts on Motor-Related Brain Fibers
Madison M Fagan, Kelly M Scheulin, Sydney E Sneed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 26, 2022
Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults
Chengjie Xiong, Jingqin Luo, Suzanne E Schindler, et al.
The Lancet. Neurology
|
September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
Page
of 49